The unique history of Wilson Sonsini Goodrich & Rosati closely traces the birth and evolution of Silicon Valley.
For more than 60 years, Wilson Sonsini has represented technology pioneers associated with virtually every milestone innovation, as well as life sciences trailblazers shaping the future of healthcare.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
Careers
We look for the best and brightest of tomorrow and develop careers from the ground up.
News and Featured Insights
Leading Matters
Client Highlights
Wilson Sonsini Advises Ferry Health on $9 Million Fundraise as Company Emerges from Stealth
On September 16, 2026, Ferry Health, an agentic artificial intelligence (AI) platform supporting patients in administrative tasks, launched out of stealth, raising $9 million in seed funding from Andreessen Horowitz (a16z), Index Ventures, Avid Ventures, Layout Ventures, SV Angel, Box Group, and Asymmetric Capital, as well as Jay Desai and the founders of Grow Therapy, Hex, and Chapter. Wilson Sonsini Goodrich & Rosati advised Ferry on the fundraising transactions.
Client Highlights
Firm Advises Ayble Health on $16 Million Series A
On September 16, 2026, Ayble Health, the nation's leading AI-enabled virtual multidisciplinary GI clinic, announced the close of a $16 million oversubscribed Series A round led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, Accomplice, and several individual strategic investors. The round brings Ayble's total capital raised to over $27 million. Wilson Sonsini Goodrich & Rosati advised Ayble on the transaction.
Client Highlights
Wilson Sonsini Advises Snorkel AI on $350 Million Series E
On September 22, 2026, Snorkel AI, the frontier AI data lab, announced it raised $350 million at a valuation of $3.5 billion. The investment will expand Snorkel AI's agentic data factory, which supplies the data and environments behind the world's most advanced AI lab systems. A Wilson Sonsini Goodrich & Rosati team led by Rezwan Pavri and Bryan King advised Snorkel AI on the transaction.
Client Highlights
Wilson Sonsini Advises The Horowitz Andreessen Academy on $42 Million Funding
On September 22, 2026, a16z announced the launch of The Horowitz Andreessen Academy (The Academy), a highly selective school in San Francisco for the most ambitious young builders after high school—giving them the skills, network, and real-world experiences to excel in a world being fundamentally reshaped by AI. The Academy raised $42 million in funding led by a16z, along with a group of angel investors including Adam D'Angelo (co-founder, Quora), Tobi Lütke (CEO, Shopify), Tony Xu (CEO, DoorDash), Fidji Simo (recently CEO of Applications, OpenAI), Garry Tan (CEO, Y Combinator), Joe Liemandt (Principal, Alpha School), and Shyam Sankar (CTO, Palantir). Wilson Sonsini Goodrich & Rosati advised The Academy on its financing round.
Client Highlights
Firm Advises CoVet on Acquisition by IDEXX
On September 16, 2026, IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. The financial terms of the transaction were not disclosed. Wilson Sonsini Goodrich & Rosati advised CoVet on the transaction.
CoVet helps veterinary teams automatically capture and organize information across the patient care journey, from consultation to treatment planning and client follow-up, reducing documentation burden and saving clinicians’ time. The acquisition expands the value of IDEXX’s software, diagnostics, and AI offerings by making information more accessible, actionable, and connected across the practice. CoVet will be integrated into the IDEXX software ecosystem, which will continue to support other ambient scribe solutions and third-party integrations. CoVet will also continue to integrate with non-IDEXX practice management systems.
The Wilson Sonsini team that advised CoVet on the transaction included:
CoVet helps veterinary teams automatically capture and organize information across the patient care journey, from consultation to treatment planning and client follow-up, reducing documentation burden and saving clinicians’ time. The acquisition expands the value of IDEXX’s software, diagnostics, and AI offerings by making information more accessible, actionable, and connected across the practice. CoVet will be integrated into the IDEXX software ecosystem, which will continue to support other ambient scribe solutions and third-party integrations. CoVet will also continue to integrate with non-IDEXX practice management systems.
The Wilson Sonsini team that advised CoVet on the transaction included:
Client Highlights
Wilson Sonsini Advises Veridion on $20 Million Series A Financing
On September 16, 2026, Veridion, a global business intelligence start-up, announced a $20 million Series A financing led by Hoxton Ventures. Underline Ventures, OTB Ventures, Gapminder, Day One Capital, and Launchub also participated in the round. Wilson Sonsini Goodrich & Rosati advised Veridion on the transaction.
The Life Sciences Report – June 2026
This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025.